{
     "PMID": "11697571",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20020206",
     "LR": "20131121",
     "IS": "0940-1334 (Print) 0940-1334 (Linking)",
     "VI": "251",
     "IP": "3",
     "DP": "2001 Jun",
     "TI": "Hippocampal 1H-MRSI in ecstasy users.",
     "PG": "114-6",
     "AB": "In recent years the illicit drug ecstasy (MDMA, 3,4-methylenedioxymethamphetamine) has come into widespread use among young people. Despite clear evidence for the neurotoxic potential of MDMA in animals, corresponding evidence in humans is limited to indirect findings. In an exploratory study we compared the hippocampal 1H-MRSI (magnetic resonance spectroscopic imaging) spectra of five MDMA users with those of controls with no history of substance abuse. Although 1H",
     "FAU": [
          "Obergriesser, T",
          "Ende, G",
          "Braus, D F",
          "Henn, F A"
     ],
     "AU": [
          "Obergriesser T",
          "Ende G",
          "Braus DF",
          "Henn FA"
     ],
     "AD": "NMR-Research, Central Institute of Mental Health P.O. Box l22120 68072 Mannheim, Germany. Tom@skullslicer.zi-mannheim.de",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article"
     ],
     "PL": "Germany",
     "TA": "Eur Arch Psychiatry Clin Neurosci",
     "JT": "European archives of psychiatry and clinical neuroscience",
     "JID": "9103030",
     "RN": [
          "0 (Serotonin Agents)",
          "30KYC7MIAI (Aspartic Acid)",
          "997-55-7 (N-acetylaspartate)",
          "KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine)",
          "MU72812GK0 (Creatine)",
          "N91BDP6H0X (Choline)"
     ],
     "SB": "IM",
     "MH": [
          "Adult",
          "Aspartic Acid/*analogs & derivatives/drug effects",
          "Brain Chemistry/drug effects",
          "Case-Control Studies",
          "Choline",
          "Creatine/drug effects",
          "Hippocampus/*drug effects/metabolism",
          "Humans",
          "*Magnetic Resonance Spectroscopy",
          "N-Methyl-3,4-methylenedioxyamphetamine/*adverse effects",
          "Serotonin Agents/*adverse effects",
          "Substance-Related Disorders/*diagnosis"
     ],
     "EDAT": "2001/11/08 10:00",
     "MHDA": "2002/02/07 10:01",
     "CRDT": [
          "2001/11/08 10:00"
     ],
     "PHST": [
          "2001/11/08 10:00 [pubmed]",
          "2002/02/07 10:01 [medline]",
          "2001/11/08 10:00 [entrez]"
     ],
     "PST": "ppublish",
     "SO": "Eur Arch Psychiatry Clin Neurosci. 2001 Jun;251(3):114-6.",
     "term": "hippocampus"
}